News & Announcements

  • Holding(s) in Company

    /**/ RNS Number : 0933I IQ-AI Limited 14 October 2024   TR-1: Standard form for notification of major holdings  1. IssuerDetails ISIN JE00BD4H0R42 Issuer Name IQ-AI LIMITED UK or Non-UK Issuer Non-UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Free Association

    Read more . . .

  • PDMR dealing and TR1 announcement

    /**/ RNS Number : 0916I IQ-AI Limited 14 October 2024   PDMR dealing and TR1 announcement Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Trevor Brown 2 Reason for the notification a)

    Read more . . .

  • Acquisition of Interest by Braveheart

    /**/ RNS Number : 8995H IQ-AI Limited 11 October 2024                                                                                                                   11 October 2024 IQ-AI Limited   IQ-AI Limited (“IQ-AI” or the “Company”) Acquisition of Interest by Braveheart Investment Group IQ-AI Limited (the “Company” or “IQ-AI”), the parent company of Wisconsin-based Imaging Biometrics, LLC (“IB”), which is focused on delivering quantitative imaging platforms and therapeutics that

    Read more . . .

  • Half-year Report

    /**/ RNS Number : 3064A IQ-AI Limited 13 August 2024   13 August 2024 IQ-AI Limited (the “Company” or the “Group”) Half Yearly Report for the Period Ended 30 June 2024 The Board of IQ-AI Ltd is pleased to announce the Company’s half yearly report for the period ended 30 June 2024. For further information,

    Read more . . .

  • IB Opens Expanded Access Program

    /**/ RNS Number : 7858T IQ-AI Limited 25 June 2024   June 25, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”)   Imaging Biometrics Opens Expanded Access Program New cancer treatment with the potential to slow brain tumor growth is now available to patients in the US with relapsed/refractory histologic or molecular glioblastoma Imaging Biometrics, LLC

    Read more . . .

TOP